Astellas Pharma Inc: all 983 studies

Page 5 of 10. Open to participants first (40), then studies with results posted, then the rest; newest registration first within each.

• Study to Assess Analgesic Efficacy and Safety of ASP3662 in Subjects With Painful Diabetic Peripheral NeuropathyTerminatedNCT02372578Phase 2
• A Study to Assess the Safety, Tolerability and Effects of Single and Multiple Ascending Doses of ASP1707 in Healthy Male and Pre-menopausal Female Subjects, Including a Comparison of the Effects Under Fasted and Fed Conditions in Healthy Young Male SubjectsCompletedNCT02368912Phase 1
• A Combined Single and Multiple Ascending Dose Study of ASP6858 in Healthy SubjectsCompletedNCT02359032Phase 1
• A Study to Evaluate ASP8232 as Add-On Therapy to Angiotensin Converting Enzyme Inhibitor (ACEi) or Angiotensin Receptor Blocker (ARB) in Reducing Albuminuria in Patients With Type 2 Diabetes and Chronic Kidney DiseaseCompletedNCT02358096Phase 2
• A Prospective Non-interventional Study in Overactive Bladder (OAB) Patients Prescribed Betmiga® as Part of Routine Clinical PracticeCompletedNCT02320773
• Phase III Study to Evaluate the Efficacy and Safety of ASP0456 in Patients With Constipation Predominant Irritable Bowel SyndromeCompletedNCT02316899Phase 3
• A Study to Assess the Safety, Tolerability and Pharmacokinetics of ASP2205 in Healthy Young Males and Females and Elderly Females and to Evaluate the Effect of Food on the Pharmacokinetics of a Single Dose of of ASP2205TerminatedNCT02314793Phase 1
• A Study to Evaluate ASP8232 in Reducing Central Retinal Thickness in Subjects With Diabetic Macular Edema (DME)CompletedNCT02302079Phase 2
• The Survey of Ipragliflozin Treatment in Elderly type2 Diabetes PatientsCompletedNCT02297620
• Post-Marketing Study to Evaluate the Long-term Safety, Tolerability, and Efficacy of Ipragliflozin in Combination With GLP-1 Receptor Agonists in Japanese Patients With Type 2 Diabetes Mellitus (T2DM)CompletedNCT02291874Phase 4
• A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ASP3700 in Healthy SubjectsWithdrawnNCT02285465Phase 1
• A Study to Evaluate the Efficacy and Safety in Kidney Transplant Recipients When Changed From Cyclosporine to Tacrolimus Prolonged-release Capsule or Tacrolimus CapsuleTerminatedNCT02268201Phase 4
• Efficacy and Safety of Two Anti-T-lymphocyte Immune Globulin (ATG-F) Induction Regimens in Anew Kidney Transplant PatientsCompletedNCT02267512Phase 4
• A Phase IIIB/IV Study to Compare the Efficacy of Vancomycin Therapy to Extended Duration of Fidaxomicin Therapy in the Clinical Cure of Clostridium Difficile Infection (CDI) in an Older PopulationCompletedNCT02254967Phase 4
• A Study to Evaluate the Effects of Multiple Doses of FG-4592 on the Exposure, Safety and Tolerability and Effect of Warfarin in Healthy SubjectsCompletedNCT02252731Phase 1
• A Study to Assess the Safety, Tolerability, and Effects in and on the Body of Healthy Young and Elderly Male and Female Subjects of Ascending Multiple Oral Doses of ASP3652CompletedNCT02243657Phase 1
• A Study of ASP2215 in Combination With Induction and Consolidation Chemotherapy in Patients With Newly Diagnosed Acute Myeloid LeukemiaCompletedNCT02236013Phase 1
• A Medical Chart Review of Patients With X-Linked Myotubular Myopathy (XLMTM)CompletedNCT02231697
• A Study to Evaluate How Daily Dosing With Enzalutamide Affects the Metabolism of Caffeine and Dextromethorphan in Men With Prostate CancerCompletedNCT02225093Phase 1
• A Study to Assess the Effects of Single Ascending Doses (SAD) of ASP8477, the Effect That Food Has on the Drug, and the Interaction Between ASP8477 and Omeprazole in Healthy Postmenopausal Females and Healthy Young Vasectomized MalesCompletedNCT02220777Phase 1
• A Study to Evaluate the Pharmacokinetics, Pharmacodynamics and Safety of ASP8232 in Subjects With Renal Impairment and in Type 2 Diabetes Mellitus Subjects With Chronic Kidney DiseaseCompletedNCT02218099Phase 1/2
• Description of the Use of fidAxomicin in Hospitalized Patients With Documented Clostridium diFficile iNfection and of the managEment of These PatientsCompletedNCT02214771
• A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Mirabegron OCAS (Oral Controlled Absorption System) in Pediatric Subjects With Neurogenic Detrusor Overactivity or Overactive BladderCompletedNCT02211846Phase 1
• A Positron Emission Tomography Occupancy Study Using Ligand [11C]AS2471907 and Following Oral Dosing of ASP3662CompletedNCT02194491Phase 1
• An Open Study of ASP8273 in Patients With Non-Small-Cell Lung Cancer (NSCLC) Who Have Epidermal Growth Factor Receptor (EGFR) MutationsTerminatedNCT02192697Phase 1/2
• Dose Escalation Study to Investigate the Safety, Tolerability and Pharmacokinetics of ASP2215 in Japanese Patients With Relapsed or Refractory Acute Myeloid LeukemiaCompletedNCT02181660Phase 1
• A Study to Evaluate the Tolerability and Efficacy of Tamsulosin 0.4mg OCAS Formulation in Patients Who Are Unsatisfied With the Treatment of Tamsulosin 0.2mg Conventional FormulationCompletedNCT02180789Phase 4
• A Study to Compare Safety and Efficacy of OPT-80(Fidaxomicin) With Vancomycin in Subjects With Clostridium Difficile-associated Diarrhea (CDAD)CompletedNCT02179658Phase 3
• A Study to Assess the Efficacy and Safety of Ipragliflozin in Combination With Insulin in Subjects With Type 2 Diabetes MellitusCompletedNCT02175784Phase 4
• A Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Escalating Doses of AGS67E Given as Monotherapy in Subjects With Refractory or Relapsed Lymphoid MalignanciesCompletedNCT02175433Phase 1
• A Study to Assess the Interaction Between ASP1707 and Itraconazole in Healthy Female SubjectsCompletedNCT02175407Phase 1
• A Study of Efficacy and Safety of Qutenza in Patients With Post-operative Peripheral Neuropathic PainCompletedNCT02171182
• A Dose Escalation Study to Assess Safety, Tolerability and Pharmacokinetics of ASP2409 Following a Single Intravenous Dose in Patients With Rheumatoid Arthritis on MethotrexateCompletedNCT02171143Phase 1
• Study to Evaluate the Effect of Solifenacin and Mirabegron on the Tamsulosin Hydrochloride (HCl) Concentrations in Blood in Healthy Male SubjectsCompletedNCT02169713Phase 1
• A Study to Evaluate the Dose-proportionality and Effects of FG-4592 in Healthy Young and Elderly Male and Female SubjectsCompletedNCT02161796Phase 1
• Asian Study to Investigate Safety and Efficacy of Optimized Dosing of Advagraf in Kidney TransplantationCompletedNCT02161237Phase 4
• A Study to Investigate the Exposure and Safety and Tolerability of a Single Dose of FG-4592 in Subjects With Moderately Diminished Liver Function Compared to Those With Normal Liver FunctionCompletedNCT02161224Phase 1
• Specified Drug Use-results Survey of Graceptor in Patients With Kidney Transplantation (Switching From Cyclosporine)CompletedNCT02160054
• A Survey for Long-term Use of Prograf Capsules in Patient With Interstitial PneumoniaCompletedNCT02159651
• A Study to Assess the Safety, Tolerability and Pharmacokinetics of ASP3700 in Healthy Male SubjectsCompletedNCT02155504Phase 1
• A Study to Evaluate a Single Intravenous (IV) Dose Using a New Manufactured Clone and Single Ascending Doses of Subcutaneous (SC) InjectionsCompletedNCT02150070Phase 1
• A Study of Renal Transplant Patients Converted From the Twice Per Day Form of Tacrolimus (Prograf®) to the Once Per Day Form (Advagraf®)CompletedNCT02147938
• A Study to Assess the Effects of Single Ascending Doses of ASP1707 in Healthy Young Japanese Male SubjectsCompletedNCT02146742Phase 1
• A Multicenter Study in Liver Transplant Patients Converted From Prograf® to Advagraf® During the First Post-transplantation YearCompletedNCT02143479
• A Study to Assess the Safety, Tolerability and Pharmacokinetics of ASP015K in Healthy SubjectsCompletedNCT02141425Phase 1
• A Study to Evaluate the Safety of ASP2408 After Subcutaneous Administration to Healthy Male SubjectsCompletedNCT02140125Phase 1
• A Study to Evaluate How a Drug That Alters Liver Enzymes (Rifampin) Affects the Metabolism of Enzalutamide in MenCompletedNCT02138799Phase 1
• A Study to Compare How Tamsulosin is Absorbed to the Body After Administration of Two Types of Tamsulosin Formulation Under Fed and Fasted Conditions in Chinese Healthy SubjectsCompletedNCT02138773Phase 1
• A Study to Investigate the Effect of Severely Diminished Liver Function on the Metabolism, Safety, and Tolerability of a Single Oral Dose of Enzalutamide in MenCompletedNCT02138162Phase 1
• A Study to Assess the Safety, Tolerability and Pharmacokinetics (PK) of Multiple Ascending Doses of ASP7962 in Healthy SubjectsCompletedNCT02136316Phase 1
• A Study to Evaluate the Effect of ASP7991 in Secondary Hyperparathyroidism Patients Undergoing HemodialysisCompletedNCT02133404Phase 2
• A Study to Evaluate the Effect of Multiple Doses of Esomeprazole on the Pharmacokinetics of IsavuconazoleCompletedNCT02128893Phase 1
• An Observational Study Looking at How Well the Drug Eligard Works and How Well it is Tolerated by the Body of Patients With Advanced Prostate Carcinoma in the Russian FederationCompletedNCT02128334
• A Study to Evaluate the Effect of Multiple Doses of Isavuconazole on the Pharmacokinetics of Repaglinide and CaffeineCompletedNCT02128321Phase 1
• Use of Micafungin (Mycamine®) as Antifungal Prophylaxis in Haematology and Onco-haematologyCompletedNCT02127788
• Study to Evaluate the Effect of Solifenacin and Mirabegron on the Digoxin Concentrations in Blood in Healthy SubjectsCompletedNCT02127034Phase 1
• A Dose Escalation Study to Assess the Safety, Tolerability, and Pharmacokinetics of ASP2408 Following Single Intravenous Doses in Healthy SubjectsCompletedNCT02125435Phase 1
• A Study to Monitor the Safety of Enzalutamide in Patients With Progressive Castration-Resistant Prostate Cancer Previously Treated With Docetaxel-Based ChemotherapyCompletedNCT02124668Phase 2
• A Dose Escalation Study of ASP8273 in Subjects With Non-Small-Cell Lung Cancer (NSCLC) Who Have Epidermal Growth Factor Receptor (EGFR) MutationsCompletedNCT02113813Phase 1
• A Study to Evaluate the Effect of Verapamil on the Pharmacokinetics of ASP015K in Healthy Adult SubjectsCompletedNCT02111317Phase 1
• Ribomustin in the First Line Therapy of Chronic Lymphocytic LeukemiaCompletedNCT02110394
• A Study to Assess the Safety and Tolerability, Including Gastrointestinal Safety, Pharmacokinetics and Pharmacodynamics of ASP7657 in Caucasian Healthy Male and Female SubjectsTerminatedNCT02108548Phase 1
• A Study to Evaluate the Effect of ASP1707 on the Bodies of Healthy Male Subjects After a Single Dose of Radioactive ASP1707CompletedNCT02106780Phase 1
• An Evaluation of a Cytomegalovirus (CMV) Vaccine (ASP0113) in CMV-Seropositive and CMV-Seronegative Healthy Subjects and CMV-Seronegative Dialysis PatientsCompletedNCT02103426Phase 1
• A Study of Escalating Doses of ASG-22CE Given as Monotherapy in Subjects With Metastatic Urothelial Cancer and Other Malignant Solid Tumors That Express Nectin-4CompletedNCT02091999Phase 1
• A Study to Evaluate Quality of Life in Patients Switched to Solifenacin From Other AntimuscarinicsCompletedNCT02087098
• A Study to Assess the Effects of Multiple Doses of Fidaxomicin on a Single Dose of Rosuvastatin in Healthy Male SubjectsCompletedNCT02083627Phase 1
• Ribomustin in the Second Line Therapy of Relapsed or Refractory Indolent B-cell Non-Hodgkin's LymphomaCompletedNCT02072967
• A Study to Describe Patterns of Care and Outcomes of Men Who Are at High Risk After Experiencing Biochemical Failure Following Definitive Prostate Cancer Therapy, Men With Castration-resistant Prostate Cancer and Men With Metastatic Prostate CancerCompletedNCT02066961
• A Study Into Pain Relief Given by ASP8477 for Peripheral Neuropathic Pain (Either Post-herpetic Neuralgia or Painful Diabetic Peripheral Neuropathy) and Its SafetyCompletedNCT02065349Phase 2
• A Study to Evaluate the Pharmacokinetics of BAL8728 After a Single Dose of Pyridinylmethyl-14C-Labeled Isavuconazonium Sulfate in Healthy Male SubjectsCompletedNCT02059590Phase 1
• A 5 Year Follow-up of Patients Who Were Previously Enrolled Into an Advagraf Trial Following a Liver or Kidney TransplantCompletedNCT02057484
• A Rollover Study for Subjects That Have Participated in an Astellas Sponsored Linsitinib TrialCompletedNCT02057380Phase 2
• Phase 1 Trial of IMAB027 in Patients With Recurrent Advanced Ovarian Cancer (OVAR)CompletedNCT02054351Phase 1
• A Study To Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of ASP2408 After Multiple Dose Subcutaneous Injections in Patients With Rheumatoid Arthritis on MethotrexateCompletedNCT02052375Phase 1
• A Study to Assess the Pharmacokinetics, Metabolism and Excretion Routes of ASP3652 in Man, After Administration of 14C Radio Labeled ASP3652CompletedNCT02046798Phase 1
• A Study to Evaluate the Efficacy and Safety of ASP4901 in Patients With Benign Prostate HyperplasiaCompletedNCT02038868Phase 2
• An Open-label Phase I Study of Orally Available Novel Small-molecule Fibroblast Growth Factor Receptors (FGFR) 1,2,3 and 4 Inhibitor, ASP5878 at Single and Multiple Doses in Patients With Solid TumorsCompletedNCT02038673Phase 1
• A Study to Assess the Efficacy and Safety of Advagraf® Switching From Cyclosporine Between the Group That Was Treated With a 50% Reduced Corticosteroid and the Group With Maintained Corticosteroid for Stable Kidney Transplant RecipientsCompletedNCT02034747Phase 4
• A Study to Investigate the Appearance and Disappearance of ASP3652 in Blood and Spinal Fluid in Healthy Male SubjectsCompletedNCT02034734Phase 1
• A Study to Compare How Much Solifenacin Succinate and Mirabegron Reach the Blood When Administered Together as Fixed-dose Combination Tablets and With Single Individual Tablets of the Same Medications at Three Dose LevelsCompletedNCT02010944Phase 1
• A Dose Escalation Study to Assess the Safety, Tolerability, and Pharmacokinetics of ASP4058 Following Single Oral DosesCompletedNCT01998646Phase 1
• A Study to Evaluate the Efficacy and Safety of Micafungin Against Invasive Candidiasis or CandidemiaTerminatedNCT01982071Phase 4
• Post-marketing Study of Gabapentin Enacarbil to Evaluate the Effect in Restless Leg Syndrome (RLS) Patients With Moderate Renal ImpairmentCompletedNCT01981941Phase 4
• A Clinical Trial to Investigate Safety and Tolerability of ASP7962 in Healthy HumansCompletedNCT01981928Phase 1
• A Study to Compare the Oral Absorption of ASP1941 Among Two Types of TabletsCompletedNCT01972880Phase 1
• ASP1517 Phase 2 Clinical Trial - Double-Blind Study of ASP1517 for the Treatment of Anemia in Chronic Kidney Disease Patients Not on Dialysis-CompletedNCT01964196Phase 2
• Post-marketing Study to Evaluate the Effect of Mirabegron on the Plasma Concentration of TolterodineCompletedNCT01964183Phase 4
• A Study to Compare the Effect of ASP3550 With Goserelin in Patients With Prostate CancerCompletedNCT01964170Phase 3
• ASG-15ME is a Study of Escalating Doses of AGS15E Given as Monotherapy in Subjects With Metastatic Urothelial CancerCompletedNCT01963052Phase 1
• Drug-Drug Interaction Study Evaluating Effects of ASP015K on RosuvastatinCompletedNCT01959399Phase 1
• A Study to Assess the Effect of Race on How a Single Dose of ASP3652 is Taken up, Metabolized and Distributed Through the Bodies of Young, Healthy Male and Female Subjects, and Its Safety and TolerabilityCompletedNCT01958047Phase 1
• A Study to Compare the Amount of Drug in the Blood After a Single Tablet EC905 Containing Solifenacin and Tamsulosin is Taken by Healthy Males Compared to Separate Tablets of Solifenacin and TamsulosinCompletedNCT01953887Phase 1
• A Study to Evaluate Whether Food Has an Effect on the Uptake of Solifenacin and Tamsulosin When Administered in a Combination TabletCompletedNCT01953861Phase 1
• A Study to Evaluate How Tamsulosin (at 1 Dose) and Solifenacin (at 2 Different Doses) Are Taken up From the Intestine, Distributed Through the Body and Eliminated From the Body When Administered in Combination as a Single Tablet (Called EC905)CompletedNCT01953848Phase 1
• A Study to Evaluate Whether Verapamil Has an Effect on the Uptake and Elimination of Solifenacin and Tamsulosin When Administered in a Combination TabletCompletedNCT01943487Phase 1
• A Study in Patients With Metastatic Prostate Cancer to Assess How the Drug Eligard®, Affects Certain Markers in Blood and Urine, Which Are Indicators for the DiseaseTerminatedNCT01933022Phase 4
• A Study to Assess the Relative Bioavailability Between Two ASP015K Tablets and the Food Effect of a New Tablet in Healthy Adult SubjectsCompletedNCT01929577Phase 1
• Oral Multiple-dose Study in Patients With Major Depressive DisorderCompletedNCT01924520Phase 1
• Drug Use-Results Survey of Betanis Tablets in JapanCompletedNCT01919047

← Astellas Pharma Inc overview and focus areas